
Blog
Hepatitis B Vaccine Market to Reach USD 13.02 Billion by 2032 at 5.17% CAGR
The Hepatitis B Vaccine Market is entering a strong growth phase, fueled by rising global vaccination campaigns, birth-dose mandates, and expanding healthcare access across emerging